Rosuvastatin compared with atorvastatin, simvastatin, and pravastatin for lipid ratios (STELLAR trial results)

被引：0

作者：

Stein, EA

Jones, PH

Deedwania, PC

Littlejohn, TWIII

Cain, VA

Raza, A

Blasetto, JW

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Univ Calif San Francisco, San Francisco, CA 94143 USA

[3] Forsyth Mem Hosp, Winston Salem, NC USA

[4] AstraZeneca LP, Wilmington, DE USA

来源：

ATHEROSCLEROSIS SUPPLEMENTS | 2003年 / 4卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：168 / 168

页数：1

共 50 条

[1] Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial
McKenney, JM
Jones, PH
Adamczyk, MA
Cain, VA
Bryzinski, BS
Blasetto, JW
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (08) : 689 - 698
[2] Lipid and apolipoprotein ratios: Association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin
Rader, DJ
Davidson, MH
Caplan, RJ
Pears, JS
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (5A): : 20C - 23C
[3] Lipid and apolipoprotein ratios: Association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin - Discussion
Stein, EA
Shepherd, J
Barter, P
Hobbs, R
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (5A): : 23C - 24C
[4] Rosuvastatin improves apolipoproteins A-1 and B more than atorvastatin, simvastatin, and pravastatin (STELLAR trial results)
Stein, EA
Jones, PH
Rhyne, JM
Caplan, R
Gold, A
Blasetto, JW
[J]. ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 168 - 168
[5] Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: Additional results from the STELLAR trial
Jones, PH
Hunninghake, DB
Ferdinand, KC
Stein, EA
Gold, A
Caplan, RJ
Blasetto, JW
[J]. CLINICAL THERAPEUTICS, 2004, 26 (09) : 1388 - 1399
[6] Cost-effectiveness analysis of rosuvastatin compared to atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin
Benner, JS
Smith, TW
Klingman, D
Tierce, JC
Mullins, CD
Pethick, N
O'Donnell, J
[J]. VALUE IN HEALTH, 2004, 7 (03) : 323 - 323
[7] Cost effectiveness of Rosuvastatin in treating patients to low-density lipoprotein cholesterol goals compared with Atorvastatin, Pravastatin, and Simvastatin (a US analysis of the STELLAR trial)
Miller, PSJ
Smith, DG
Jones, P
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (11): : 1314 - 1319
[8] Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: Additional results from the STELLAR trial (vol 26, pg 1388, 2004)
Jones, PH
[J]. CLINICAL THERAPEUTICS, 2005, 27 (01) : 142 - 142
[9] Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial
Hirsch, M
O'Donnel, JC
Jones, P
[J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2005, 12 (01): : 18 - 28
[10] Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvalstaltin, and pravastatin across doses (STELLAR* trial)
Jones, PH
Davidson, MH
Stein, EA
Bays, HE
McKenney, JM
Miller, E
Cain, VA
Blasetto, JW
STELLAR Study Grp
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (02): : 152 - 160

← 1 2 3 4 5 →